


The Fund's aim is to achieve long-term capital growth from a UK equity portfolio comprising our 'best ideas' within the UK market.
| Name | % Net Assets |
|---|---|
| Healthcare Locums | 5.7% |
| Pace | 5.4% |
| Afren | 5.1% |
| Firstgroup | 4.1% |
| Melrose | 3.6% |
| International Power | 3.5% |
| C&C Group (Irish) | 3.5% |
| Valiant Petroleum | 3.4% |
| Innovation Group | 3.2% |
| Norseman Gold Resources | 3.1% |
| Key | % Net Assets |
|---|---|
| 5.7% | |
| 5.4% | |
| 5.1% | |
| 4.1% | |
| 79.7% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 667.10p |
| Currency | GBP |
| Change | -1.60p |
| % | -0.24% |
| YTD change | 75.50p |
| YTD % | 12.76% |
| Fund Inception | 20/03/2000 |
|---|---|
| Fund Manager | Neil Veitch / Margaret Lawson |
| TER | 1.85 (31-Dec-2013) |
| Minimum Investment | |
|---|---|
| Initial | £1000 |
| Additional | £200 |
| Savings | £200 |
| Charges | |
|---|---|
| Initial | 5.25% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.17 |
You are here: research